Log in to save to my catalogue

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782210

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

About this item

Full title

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2016-03, Vol.114 (5), p.519-523

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background:
Multiple myeloma (MM) is an incurable clonal plasma cell malignancy. The constitutive expression of HIF-1
α
in MM suggests that inhibition of HIF-1
α
-mediated transcription represents an interesting target in MM.
Methods:
As p300 is a crucial co-activator of hypoxia-inducible transcription, disrupting the complex H...

Alternative Titles

Full title

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782210

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782210

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/bjc.2016.20

How to access this item